
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
A retrospective look at some of the photographs Contemporary Pediatrics received from its photo contest.
One more time, Contemporary Pediatrics is sharing some of the many entries from our photo contest. Thanks for all the great images! Check out lots more at






